Mary Cushman
Mary Cushman publishes mostly in Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology, on topics such as Venous Thromboembolism Diagnosis and Management, Blood Coagulation and Thrombosis Mechanisms and Cardiovascular Health and Risk Factors.
- World rank
- #26,643 of 7,710,434 ranked researchers
- Rank in United States
- #9,979 of 1,627,098
- Works
- 1,332
- Citations
- 140k
- Citations per work
- 105.2
What does Mary Cushman research?
Mary Cushman's work is mostly in Medicine (49%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else68551.4%
- Health Sciences64748.6%
- Medicine64748.6%
- 1Cardiology and Cardiovascular Medicine17% of their works
- 2Internal Medicine8% of their works
- 3Epidemiology8% of their works
- 4Hematology7% of their works
- 5Surgery5% of their works
- 6Endocrinology, Diabetes and Metabolism4% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Blood Coagulation and Thrombosis Mechanisms
- Cardiovascular Health and Risk Factors
- Acute Ischemic Stroke Management
- Adipokines, Inflammation, and Metabolic Diseases
- Atrial Fibrillation Management and Outcomes
- Blood properties and coagulation
- Lipoproteins and Cardiovascular Health
Which keywords describe Mary Cushman's research?
The keywords of their largest research topics: Risk Factors, Antithrombotic Therapy, Pulmonary Embolism, Venous Thromboembolism, Inflammation, Hemostasis, C-Reactive Protein and Protease-Activated Receptors.
- Cholesterol-lowering
- Fibrinogen
- Anticoagulant Therapy
- Adipose Tissue
- Ischemic Stroke
- Cardiovascular Health
- Protease-Activated Receptors
- Hemostasis
- Venous Thromboembolism
- Antithrombotic Therapy
- Risk Factors
- Pulmonary Embolism
- Inflammation
- C-Reactive Protein
- Thrombin
- Ideal Cardiovascular Health
- Thrombolysis
- Obesity
- Atrial Fibrillation
- Transglutaminases
- Statins
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Risk Factors5213 topics
- Antithrombotic Therapy4342 topics
- Pulmonary Embolism2691 topic
- Venous Thromboembolism2691 topic
- Inflammation2682 topics
- Hemostasis2362 topics
- C-Reactive Protein1692 topics
- Protease-Activated Receptors1651 topic
- Thrombin1651 topic
- Cardiovascular Health1331 topic
- Ideal Cardiovascular Health1331 topic
- Ischemic Stroke1191 topic
- Thrombolysis1191 topic
- Adipose Tissue1031 topic
- Obesity1031 topic
- Anticoagulant Therapy901 topic
- Atrial Fibrillation901 topic
- Fibrinogen711 topic
- Transglutaminases711 topic
- Cholesterol-lowering661 topic
- Statins661 topic
Where does Mary Cushman work?
Mary Cushman's main affiliation in the publication record is University of Vermont, United States.
How many publications and citations does Mary Cushman have?
OpenAlex counts 1,332 works and 140,141 citations for Mary Cushman, an h-index of 139, ranking #26,643 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Mary Cushman
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mary Cushman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.